Next Article in Journal
Autophagy and Nutrients Management in Plants
Next Article in Special Issue
Ending Restenosis: Inhibition of Vascular Smooth Muscle Cell Proliferation by cAMP
Previous Article in Journal
Combinatory Multifactor Treatment Effects on Primary Nanofiber Oligodendrocyte Cultures
Previous Article in Special Issue
Genome-Wide Mapping Defines a Role for C/EBPβ and c-Jun in Non-Canonical Cyclic AMP Signalling
Open AccessArticle

Identification of A Novel Class of Benzofuran Oxoacetic Acid-Derived Ligands that Selectively Activate Cellular EPAC1

European Screening Centre Newhouse, University of Dundee, Biocity Scotland, Bo’Ness Road, Newhouse, Lanarkshire ML1 5UH, UK
Department of Physiology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Pivot Park Screening Centre, Kloosterstraat 9, 5349 AB Oss, The Netherlands
Structural Genomics Consortium, University of Oxford, Oxford OX3 7DQ, UK
Institute of Biological Chemistry, Biophysics and Bioengineering, School of Engineering and Physical Sciences, Heriot-Watt University, Edinburgh Campus, Edinburgh EH14 4AS, UK
Institute of Chemical Sciences, Heriot-Watt University, Edinburgh EH14 4AS, UK
Department of Molecular Cancer Research, Centre of Biomedical Genetics and Cancer Genomics Centre, University Medical Centre Utrecht, 3508 TC Utrecht, The Netherlands
Author to whom correspondence should be addressed.
Cells 2019, 8(11), 1425;
Received: 8 October 2019 / Revised: 6 November 2019 / Accepted: 7 November 2019 / Published: 12 November 2019
(This article belongs to the Special Issue New Advances in Cyclic AMP Signalling)
Cyclic AMP promotes EPAC1 and EPAC2 activation through direct binding to a specific cyclic nucleotide-binding domain (CNBD) within each protein, leading to activation of Rap GTPases, which control multiple cell responses, including cell proliferation, adhesion, morphology, exocytosis, and gene expression. As a result, it has become apparent that directed activation of EPAC1 and EPAC2 with synthetic agonists may also be useful for the future treatment of diabetes and cardiovascular diseases. To identify new EPAC agonists we have developed a fluorescent-based, ultra-high-throughput screening (uHTS) assay that measures the displacement of binding of the fluorescent cAMP analogue, 8-NBD-cAMP to the EPAC1 CNBD. Triage of the output of an approximately 350,000 compound screens using this assay identified a benzofuran oxaloacetic acid EPAC1 binder (SY000) that displayed moderate potency using orthogonal assays (competition binding and microscale thermophoresis). We next generated a limited library of 91 analogues of SY000 and identified SY009, with modifications to the benzofuran ring associated with a 10-fold increase in potency towards EPAC1 over SY000 in binding assays. In vitro EPAC1 activity assays confirmed the agonist potential of these molecules in comparison with the known EPAC1 non-cyclic nucleotide (NCN) partial agonist, I942. Rap1 GTPase activation assays further demonstrated that SY009 selectively activates EPAC1 over EPAC2 in cells. SY009 therefore represents a novel class of NCN EPAC1 activators that selectively activate EPAC1 in cellulae. View Full-Text
Keywords: cyclic AMP; EPAC; uHTS; Rap1; guanine nucleotide exchange factor (GEF) activity; agonists cyclic AMP; EPAC; uHTS; Rap1; guanine nucleotide exchange factor (GEF) activity; agonists
Show Figures

Figure 1

MDPI and ACS Style

Beck, E.M.; Parnell, E.; Cowley, A.; Porter, A.; Gillespie, J.; Robinson, J.; Robinson, L.; Pannifer, A.D.; Hamon, V.; Jones, P.; Morrison, A.; McElroy, S.; Timmerman, M.; Rutjes, H.; Mahajan, P.; Wiejak, J.; Luchowska-Stańska, U.; Morgan, D.; Barker, G.; Rehmann, H.; Yarwood, S.J. Identification of A Novel Class of Benzofuran Oxoacetic Acid-Derived Ligands that Selectively Activate Cellular EPAC1. Cells 2019, 8, 1425.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop